Literature DB >> 28992723

Severe cerebellar hemorrhage following transverse sinus stenting for idiopathic intracranial hypertension.

Pascale Lavoie1, Marie-Ève Audet2, Jean-Luc Gariepy2, Martin Savard1, Steve Verreault1, Alain Gourdeau3, Geneviève Milot1, Sylvine Carrondo Cottin1.   

Abstract

We report a severe adverse event occurring in the course of a cohort study (ISRCTN13784335) aimed at measuring the efficacy and safety of venous stenting in the treatment of patients with medically refractory idiopathic intracranial hypertension (IIH). The patient was a 41-year-old woman who was not overweight, who presented with severe headache, grade 1 bilateral papilledema and transient tinnitus, refractory to medical treatment. Right transverse sinus stenting was successfully performed. Following surgery, the patient's state of consciousness decreased acutely with rapid and progressive loss of brainstem reflex. CT scan revealed acute cerebellar and intraventricular hemorrhage with obstructive hydrocephalus. Angioscan revealed normal venous sinus patency and cerebral MRI showed acute mesencephalic ischemia. Mechanical impairment of cerebellar venous drainage by the stent or venous perforation with the large guidewire used in this technique are two logical ways to explain the cerebellar hemorrhage seen in our patient. The risk of such a complication could probably be reduced using alternative tools and technique. However, given the low level of evidence around the safety of transverse sinus stenting in IIH, its formal assessment in clinical trials is required.

Entities:  

Keywords:  Idiopathic intracranial hypertension; hemorrhage; stenting

Mesh:

Year:  2017        PMID: 28992723      PMCID: PMC5772537          DOI: 10.1177/1591019917734389

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  26 in total

1.  Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure.

Authors:  Devra B Baryshnik; Richard I Farb
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

2.  Resolution of transverse sinus stenosis in idiopathic intracranial hypertension after L-P shunt.

Authors:  A McGonigal; I Bone; E Teasdale
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

3.  Parallel transverse-sigmoid sinus harboring dural arteriovenous malformation. How to differentiate the pathological and normal sinus in order to treat and preserve patency and function.

Authors:  César de Paula Lucas; Mirto Nelso Prandini; Laurent Spelle; Michel Piotin; Charbel Mounayer; Jacques Moret
Journal:  Acta Neurochir (Wien)       Date:  2009-06-11       Impact factor: 2.216

4.  Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results.

Authors:  Felipe C Albuquerque; Shervin R Dashti; Yin C Hu; C Benjamin Newman; Mohamed Teleb; Cameron G McDougall; Harold L Rekate
Journal:  World Neurosurg       Date:  2011 May-Jun       Impact factor: 2.104

5.  Transverse venous sinus stent placement as treatment for benign intracranial hypertension in a young male: case report and review of the literature.

Authors:  Sharad Rajpal; David B Niemann; Aquilla S Turk
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

6.  Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.

Authors:  Marc J Dinkin; Athos Patsalides
Journal:  J Neuroophthalmol       Date:  2017-06       Impact factor: 3.042

7.  Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis.

Authors:  R I Farb; I Vanek; J N Scott; D J Mikulis; R A Willinsky; G Tomlinson; K G terBrugge
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

8.  Lateral sinus stenoses in idiopathic intracranial hypertension resolving after CSF diversion.

Authors:  J Nicholas P Higgins; John D Pickard
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

Review 9.  Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting.

Authors:  J N P Higgins; C Cousins; B K Owler; N Sarkies; J D Pickard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

10.  Venous sinus stenting for refractory benign intracranial hypertension.

Authors:  J Nicholas P Higgins; Brian K Owler; Claire Cousins; John D Pickard
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

View more
  5 in total

1.  Safely traversing venous sinus stenosis: The "Cobra" technique.

Authors:  Justin Schwarz; Alejandro Santillan; Athos Patsalides
Journal:  Interv Neuroradiol       Date:  2019-12-19       Impact factor: 1.610

Review 2.  A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH).

Authors:  Aristotelis Kalyvas; Eleftherios Neromyliotis; Christos Koutsarnakis; Spyridon Komaitis; Evangelos Drosos; Georgios P Skandalakis; Mantha Pantazi; Y Pierre Gobin; George Stranjalis; A Patsalides
Journal:  Neurosurg Rev       Date:  2020-04-25       Impact factor: 3.042

Review 3.  Exploring The Current Management Idiopathic Intracranial Hypertension, And Understanding The Role Of Dural Venous Sinus Stenting.

Authors:  Sam P Gurney; Sateesh Ramalingam; Alan Thomas; Alex J Sinclair; Susan P Mollan
Journal:  Eye Brain       Date:  2020-01-14

4.  Intracranial Venous Sinus Stenting in Idiopathic Intracranial Hypertension: A Case Report and Review of the Literature.

Authors:  Dinesh Ramanathan; Zachary D Travis; Emmanuel Omosor; Taylor Wilson; Nikhil Sahasrabudhe; Anish Sen
Journal:  Brain Sci       Date:  2021-03-17

5.  Casper Versus Precise Stent for the Treatment of Patients with Idiopathic Intracranial Hypertension.

Authors:  Nebiyat F Belachew; Severin Baschung; William Almiri; Ruben Encinas; Johannes Kaesmacher; Tomas Dobrocky; Christoph J Schankin; Mathias Abegg; Eike I Piechowiak; Andreas Raabe; Jan Gralla; Pasquale Mordasini
Journal:  Clin Neuroradiol       Date:  2021-05-18       Impact factor: 3.649

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.